Renal failure is a well‐recognized complication of multiple myeloma (MM), occurring in approximately 50% of patients at diagnosis. However, dialysis‐dependent renal failure as the dominant presenting feature of newly diagnosed MM remains uncommon, affecting only 2%–4% of patients, and poses distinct diagnostic and therapeutic challenges. A 73‐year‐old woman with no prior history of kidney disease presented with altered mental status and was found to have a creatinine of 20.29 mg/dL, hemoglobin of 5.2 g/dL, and free kappa light chains exceeding 3000 mg/dL. Neuroimaging obtained during workup incidentally revealed extensive lytic skull lesions, further consolidating clinical suspicion for MM. Serum protein electrophoresis confirmed IgA kappa monoclonal gammopathy. The patient was diagnosed with MM complicated by uremic encephalopathy and started on hemodialysis and MM‐directed therapy. Her mental status improved significantly after two dialysis sessions. Here, we discuss the importance of including MM in the differential diagnosis of any unexplained acute renal failure, the diagnostic value of incidental neuroimaging findings, and the potential for renal recovery with bortezomib‐based therapy in the setting of myeloma‐related cast nephropathy.
Building similarity graph...
Analyzing shared references across papers
Loading...
Sree Manasa PuttamReddy
Alabama State University
Tanya M. Wildes
Nebraska Medical Center
Case Reports in Hematology
University of Nebraska Medical Center
Nebraska Medical Center
Alabama State University
Building similarity graph...
Analyzing shared references across papers
Loading...
PuttamReddy et al. (Thu,) studied this question.
synapsesocial.com/papers/6a23b9ca71a5da9775e75964 — DOI: https://doi.org/10.1155/crh/9222777
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: